Crexendo Inc Financials
This page shows Crexendo Inc (CXDO) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Crexendo’s growth is becoming highly cash generative because reinvestment needs stay minimal and debt barely finances operations.
Most recently, free cash flow margin at13.6% ran well above operating margin of6.9% , so cash generation is outpacing accounting profit rather than merely matching it. That gap fits an asset-light model: capex was only$18K , which means added sales are not being absorbed by heavy spending on fixed assets.
The company’s cash cushion of
Compared with the recent loss period, the business reached net income of
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Crexendo Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Crexendo Inc scores 11.58, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($266.1M) relative to total liabilities ($13.9M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Crexendo Inc passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Crexendo Inc generates $1.83 in operating cash flow ($9.3M OCF vs $5.1M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Crexendo Inc earns $246.8 in operating income for every $1 of interest expense ($4.7M vs $19K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Crexendo Inc generated $68.2M in revenue in fiscal year 2025. This represents an increase of 12.0% from the prior year.
Crexendo Inc's EBITDA was $4.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 130.7% from the prior year.
Crexendo Inc reported $5.1M in net income in fiscal year 2025. This represents an increase of 202.4% from the prior year.
Crexendo Inc earned $0.16 per diluted share (EPS) in fiscal year 2025. This represents an increase of 166.7% from the prior year.
Cash & Balance Sheet
Crexendo Inc generated $9.3M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 48.3% from the prior year.
Crexendo Inc held $31.4M in cash against $114K in long-term debt as of fiscal year 2025.
Crexendo Inc had 31M shares outstanding in fiscal year 2025. This represents an increase of 12.2% from the prior year.
Margins & Returns
Crexendo Inc's operating margin was 6.9% in fiscal year 2025, reflecting core business profitability. This is up 3.9 percentage points from the prior year.
Crexendo Inc's net profit margin was 7.4% in fiscal year 2025, showing the share of revenue converted to profit. This is up 4.7 percentage points from the prior year.
Crexendo Inc's ROE was 8.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 4.7 percentage points from the prior year.
Capital Allocation
Crexendo Inc invested $5.7M in research and development in fiscal year 2025. This represents an increase of 3.0% from the prior year.
Crexendo Inc invested $18K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 33.3% from the prior year.
CXDO Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $20.7M+14.7% | $18.1M+3.2% | $17.5M+5.7% | $16.6M+3.1% | $16.1M-1.1% | $16.2M+3.9% | $15.6M+6.4% | $14.7M |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | $1.6M+16.4% | $1.3M-4.8% | $1.4M-1.6% | $1.4M-5.6% | $1.5M+1.4% | $1.5M+2.0% | $1.5M+10.9% | $1.3M |
| SG&A Expenses | $5.1M+31.7% | $3.8M+1.6% | $3.8M+5.4% | $3.6M+1.9% | $3.5M+3.3% | $3.4M-7.8% | $3.7M+7.7% | $3.4M |
| Operating Income | $440K-61.1% | $1.1M-13.3% | $1.3M+18.3% | $1.1M-4.1% | $1.1M+83.7% | $626K+363.7% | $135K-76.7% | $580K |
| Interest Expense | $0 | N/A | $0 | $0 | $0 | N/A | $7K-36.4% | $11K |
| Income Tax | $29K | N/A | $43K-10.4% | $48K+9.1% | $44K | N/A | $46K+70.4% | $27K |
| Net Income | $578K-52.5% | $1.2M-16.0% | $1.4M+17.7% | $1.2M+5.2% | $1.2M+131.0% | $507K+242.6% | $148K-74.8% | $588K |
| EPS (Diluted) | $0.02-50.0% | $0.04-20.0% | $0.05+25.0% | $0.040.0% | $0.04+100.0% | $0.02 | $0.00-100.0% | $0.02 |
CXDO Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $91.3M+17.5% | $77.7M+2.3% | $76.0M+6.4% | $71.4M+5.8% | $67.4M+3.9% | $64.9M+4.3% | $62.3M+4.4% | $59.6M |
| Current Assets | $23.0M-45.0% | $41.9M+6.6% | $39.3M+13.5% | $34.6M+14.9% | $30.1M+12.2% | $26.9M+12.6% | $23.9M+9.0% | $21.9M |
| Cash & Equivalents | $7.2M-76.9% | $31.4M+9.8% | $28.6M+21.8% | $23.4M+10.6% | $21.2M+16.6% | $18.2M+17.7% | $15.5M+13.5% | $13.6M |
| Inventory | $1.2M+157.7% | $454K-29.1% | $640K+3.6% | $618K+7.3% | $576K+46.6% | $393K-24.1% | $518K-6.5% | $554K |
| Accounts Receivable | $6.4M+29.7% | $4.9M+3.5% | $4.7M-15.5% | $5.6M+38.4% | $4.1M-6.7% | $4.4M+16.0% | $3.8M-6.0% | $4.0M |
| Goodwill | $14.2M+50.4% | $9.5M0.0% | $9.5M0.0% | $9.5M0.0% | $9.5M0.0% | $9.5M0.0% | $9.5M0.0% | $9.5M |
| Total Liabilities | $18.6M+33.9% | $13.9M-5.1% | $14.6M+11.9% | $13.1M+6.8% | $12.2M-9.6% | $13.5M+5.8% | $12.8M+11.6% | $11.5M |
| Current Liabilities | $16.8M+36.2% | $12.3M-9.3% | $13.6M+12.4% | $12.1M+8.8% | $11.1M-8.1% | $12.1M+8.5% | $11.2M+6.8% | $10.4M |
| Long-Term Debt | N/A | $114K-51.7% | $236K-33.7% | $356K-25.1% | $475K-19.8% | $592K-16.5% | $709K-13.9% | $823K |
| Total Equity | $72.7M+13.9% | $63.8M+4.0% | $61.3M+5.2% | $58.3M+5.6% | $55.2M+7.4% | $51.4M+3.9% | $49.5M+2.7% | $48.2M |
| Retained Earnings | -$81.1M+0.7% | -$81.7M+1.5% | -$82.9M+1.7% | -$84.4M+1.4% | -$85.6M+1.3% | -$86.8M+0.6% | -$87.3M+0.2% | -$87.4M |
CXDO Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.0M-13.2% | $2.3M-46.9% | $4.4M+241.1% | $1.3M+4.6% | $1.2M-43.1% | $2.2M+34.3% | $1.6M-38.9% | $2.7M |
| Capital Expenditures | N/A | $0 | $0-100.0% | $18K | $0-100.0% | $27K | $0 | $0 |
| Free Cash Flow | N/A | $2.3M-46.9% | $4.4M+245.9% | $1.3M+3.2% | $1.2M-42.4% | $2.1M+32.6% | $1.6M-38.9% | $2.7M |
| Investing Cash Flow | -$26.2M | $0 | $0+100.0% | -$18K | $0+100.0% | -$27K | $0 | $0 |
| Financing Cash Flow | $61K-86.8% | $461K-36.4% | $725K-22.3% | $933K-47.1% | $1.8M+201.9% | $584K+150.6% | $233K+387.7% | -$81K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | $0 | $0 | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
CXDO Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | 2.1%-4.2pp | 6.3%-1.2pp | 7.5%+0.8pp | 6.7%-0.5pp | 7.2%+3.3pp | 3.9%+3.0pp | 0.9%-3.1pp | 4.0% |
| Net Margin | 2.8%-4.0pp | 6.7%-1.6pp | 8.3%+0.9pp | 7.4%+0.1pp | 7.3%+4.2pp | 3.1%+2.2pp | 0.9%-3.0pp | 4.0% |
| Return on Equity | 0.8%-1.1pp | 1.9%-0.5pp | 2.4%+0.2pp | 2.1%0.0pp | 2.1%+1.1pp | 1.0%+0.7pp | 0.3%-0.9pp | 1.2% |
| Return on Assets | 0.6%-0.9pp | 1.6%-0.3pp | 1.9%+0.2pp | 1.7%0.0pp | 1.7%+1.0pp | 0.8%+0.5pp | 0.2%-0.8pp | 1.0% |
| Current Ratio | 1.37-2.0 | 3.40+0.5 | 2.89+0.0 | 2.86+0.1 | 2.71+0.5 | 2.22+0.1 | 2.14+0.0 | 2.10 |
| Debt-to-Equity | 0.26+0.3 | 0.000.0 | 0.000.0 | 0.010.0 | 0.010.0 | 0.010.0 | 0.010.0 | 0.02 |
| FCF Margin | N/A | 13.0%-12.3pp | 25.2%+17.5pp | 7.7%+0.0pp | 7.7%-5.5pp | 13.2%+2.9pp | 10.4%-7.7pp | 18.1% |
Similar Companies
Frequently Asked Questions
What is Crexendo Inc's annual revenue?
Crexendo Inc (CXDO) reported $68.2M in total revenue for fiscal year 2025. This represents a 12.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Crexendo Inc's revenue growing?
Crexendo Inc (CXDO) revenue grew by 12% year-over-year, from $60.8M to $68.2M in fiscal year 2025.
Is Crexendo Inc profitable?
Yes, Crexendo Inc (CXDO) reported a net income of $5.1M in fiscal year 2025, with a net profit margin of 7.4%.
What is Crexendo Inc's EBITDA?
Crexendo Inc (CXDO) had EBITDA of $4.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Crexendo Inc have?
As of fiscal year 2025, Crexendo Inc (CXDO) had $31.4M in cash and equivalents against $114K in long-term debt.
What is Crexendo Inc's operating margin?
Crexendo Inc (CXDO) had an operating margin of 6.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Crexendo Inc's net profit margin?
Crexendo Inc (CXDO) had a net profit margin of 7.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Crexendo Inc's return on equity (ROE)?
Crexendo Inc (CXDO) has a return on equity of 8.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Crexendo Inc's free cash flow?
Crexendo Inc (CXDO) generated $9.3M in free cash flow during fiscal year 2025. This represents a 48.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Crexendo Inc's operating cash flow?
Crexendo Inc (CXDO) generated $9.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Crexendo Inc's total assets?
Crexendo Inc (CXDO) had $77.7M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Crexendo Inc's capital expenditures?
Crexendo Inc (CXDO) invested $18K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Crexendo Inc spend on research and development?
Crexendo Inc (CXDO) invested $5.7M in research and development during fiscal year 2025.
What is Crexendo Inc's current ratio?
Crexendo Inc (CXDO) had a current ratio of 3.40 as of fiscal year 2025, which is generally considered healthy.
What is Crexendo Inc's debt-to-equity ratio?
Crexendo Inc (CXDO) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Crexendo Inc's return on assets (ROA)?
Crexendo Inc (CXDO) had a return on assets of 6.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Crexendo Inc's Altman Z-Score?
Crexendo Inc (CXDO) has an Altman Z-Score of 11.58, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Crexendo Inc's Piotroski F-Score?
Crexendo Inc (CXDO) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Crexendo Inc's earnings high quality?
Crexendo Inc (CXDO) has an earnings quality ratio of 1.83x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Crexendo Inc cover its interest payments?
Crexendo Inc (CXDO) has an interest coverage ratio of 246.8x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Crexendo Inc?
Crexendo Inc (CXDO) scores 54 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.